Collateral for a security interest recorded Jul 19, 2024 (Goldman Sachs Bank USA).
Term ends Jul 25, 2028 · High confidence
20-year base term ended Oct 5, 2025
Held by Endo Operations Limited
Filed Oct 5, 2005 as application 11/243,802 · Granted Mar 8, 2011
Base term plus 1024 days of patent term adjustment (USPTO delay)
Today
2005
2028
Clock starts
Oct 5, 2005
Oct 5, 2005
Term ends
Jul 25, 2028
Jul 25, 2028
Granted
Mar 8, 2011
Mar 8, 2011
base term
patent term adjustment
fee events
Updated Nov 15, 2026 · includes USPTO assignment & status data published Nov 15, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
1,024
Days of term adjustment
Read from the USPTO patent term adjustment record, not recalculated here.
None
Terminal disclaimer
No disclaimer on this record.
3 of 3
Maintenance fees paid
Three maintenance fees fall due, at 3.5, 7.5 and 11.5 years from grant. This counts the ones the record shows paid.
3
Family applications on record here
Applications sharing this one's continuity chain whose file history this site holds. The family may have others.
This patent's term runs 1024 days past its 20-year base term on prosecution delay. All three maintenance fees are recorded paid; no more fees are due. Confidence: High. from the record
How we calculated this date
One row per rule, each showing its own input and what it did to the date. A step we could not verify says so instead of resolving itself.
| Step | Input | Date after this step | Confidence |
|---|---|---|---|
| Base term, 20 years from filing | Clock starts Oct 5, 2005, when this application, 11/243,802, was filed | Oct 5, 2025 | High confidence |
| Continuity chain | Every parent in the chain resolved | no change | High confidence |
| Patent term adjustment | +1024 days, USPTO patent term adjustment record | Jul 25, 2028 | High confidence |
| Terminal disclaimer cap | None on record | no cap applied | High confidence |
| Patent term extension | None on file | no change | High confidence |
| Fee events | 3 of 3 maintenance fees paid | In force | High confidence |
| Computed term end | The steps above, in order | Jul 25, 2028 | High confidence |
This family
| US 7,901,346 | this patent Jul 2028 | Jul 2028 |
| US 8,636,643 | Term ended Dec 2025 | Dec 2025 |
| US 9,763,764 | Term ended Oct 2025 | Oct 2025 |
The applications whose file history this site holds. The family may have others.
Assignments
The 40 most recent of 57 recorded documents are shown; the 17 earliest are not. Assignment documents as recorded at the USPTO, oldest first, with the reel and frame each was recorded at. A recorded assignment is a filed document, not a statement of current ownership, and the absence of a later one is not evidence that the last one still stands.
| Recorded | Assignor | Assignee | Conveyance |
|---|---|---|---|
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Astora Women’s Health LLC | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Auxilium Pharmaceuticals, LLC | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Auxilium US Holdings, LLC | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | BioSpecifics Technologies Corp. | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | BioSpecifics Technologies LLC | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Dava International, LLC | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Dava Pharmaceuticals, LLC | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Pharmaceuticals Inc. | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Pharmaceuticals Solutions Inc. (Formerly Known as Indevus Pharmaceuticals, Inc.) | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Generics Bidco I, LLC | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Generics International (US), Inc. | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Par Pharmaceutical, Inc. | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Par Pharmaceutical Companies, Inc. | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Par Sterile Products, LLC (Formerly Known as JHP Pharmaceuticals, LLC) | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Quartz Specialty Pharmaceuticals, LLC | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Slate Pharmaceuticals, LLC | Release of Security Interest |
| Apr 25, 2024 reel/frame not recorded | Wilmington Trust, National Association | Vintage Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 Reel 67240, frame 1 | Wilmington Trust, National Association | Actient Pharmaceuticals LLC; Astora Women’s Health Holdings, LLC; Astora Women’s Health LLC; Auxilium Pharmaceuticals, LLC; Auxilium US Holdings, LLC; BioSpecifics Technologies Corp.; BioSpecifics Technologies LLC; Dava International, LLC; Dava Pharmaceuticals, LLC; Endo Generic Holdings, Inc. (Formerly Known as Par Pharmaceuticals Companies, Inc.); Endo Pharmaceuticals Inc.; Endo Pharmaceuticals Solutions Inc. (Formerly Known as Indevus Pharmaceuticals, Inc.); Generics Bidco I, LLC; Generics International (US), Inc.; Par Pharmaceutical, Inc.; Par Sterile Products, LLC (Formerly Known as JHP Pharmaceuticals, LLC); Quartz Specialty Pharmaceuticals, LLC; Slate Pharmaceuticals, LLC; Vintage Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Actient Pharmaceuticals LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Astora Women’s Health Holdings, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Astora Women’s Health LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Auxilium Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Auxilium US Holdings, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | BioSpecifics Technologies Corp. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | BioSpecifics Technologies LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Dava International, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Dava Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Generic Holdings, Inc. (Formerly Known as Par Pharmaceuticals Companies, Inc.) | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Pharmaceuticals Inc. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Endo Pharmaceuticals Solutions Inc. (Formerly Known as Indevus Pharmaceuticals, Inc.) | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Generics Bidco I, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Generics International (US), Inc. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Par Pharmaceutical, Inc. | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Par Sterile Products, LLC (Formerly Known as JHP Pharmaceuticals, LLC) | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Quartz Specialty Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Slate Pharmaceuticals, LLC | Release of Security Interest |
| Apr 26, 2024 reel/frame not recorded | Wilmington Trust, National Association | Vintage Pharmaceuticals, LLC | Release of Security Interest |
| Apr 27, 2024 Reel 67245, frame 492 | Endo USA, Inc. | Endo Operations Limited | Assignment of Assignor's Interest |
| Jul 19, 2024 Reel 68461, frame 692 | Endo Biologics Limited; Endo Operations Limited | Goldman Sachs Bank USA | Security Interest |
| Jul 22, 2024 Reel 68469, frame 1 | Endo Biologics Limited; Endo Operations Limited | Computershare Trust Company, National Association | Security Interest |
Sources
Google Patents · The patent document at USPTO · Assignment records at USPTO
USPTO account required: This application in Patent Center · USPTO's maintenance fee lookup
Maintenance fee events come from USPTO's own fee records. Its fee lookup asks for the patent number and the application number.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
What's changing
Jul 2028
Term ends Jul 25, 2028. No further fees fall due before then
Note
The 1024 days of patent term adjustment (USPTO delay) are read from the USPTO record, not recalculated by us
Citations
131
later US patents cite this one
That is top 5% of utility patents granted in 2011 in our data, the only group it is compared against.
How we rank
Every date shows its work: the base term, any term adjustment or extension, any disclaimer cap, and the maintenance fee record, each with a confidence tier. How this record was built
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.
In force means the term is running and no lapse is on record. It is not a finding that the patent is valid.